Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Alder BioPharmaceuticals® Reports Second Quarter 2019 Financial and Operating Results

Alder BioPharmaceuticals, Inc (ALDR)  More Company Research Source: GlobeNewswire
Last alder biopharmaceuticals, inc earnings: 8/6 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alderbio.com/node/5806
PDF Data presented at American Academy of Neurology and American Headache Society Annual Meetings continue to support eptinezumab’s differentiated clinical profile and impact on quality of life measures  Core commercial leadership team secured, including field payer team, in anticipation of expected eptinezumab U.S. launch in 1Q 2020, assuming FDA approval Key milestones anticipated in 2H 2019, including completed commercial footprint, start of acute study and advancement of second product candidate, ALD1910, into clinical development Conference call today at 5:00 p.m. ET BOTHELL, Wash., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today provided a corporate update and reported its financial results for the second quarter ended June 30, 2019. “We continue to make significant progress toward the potential launch of eptinezumab in the U.S. [Read more]
Impact snapshot Event time: ALDR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ALDR alerts
from News Quantified
Opt-in for
ALDR alerts

from News Quantified
Opt-in for
ALDR alerts

from News Quantified